Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082743 Polypeptide sequences of human EDG-1c
05/01/2003US20030082742 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082737 Nucleotide sequences coding polypeptide for use in the eating disorders
05/01/2003US20030082735 Selection of cells expressing heteromeric polypeptides
05/01/2003US20030082732 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082729 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082727 Modulatory proteins of human CNS receptors
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082712 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082711 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082710 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082708 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082706 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082705 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082704 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082703 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082702 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082701 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082698 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082697 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082696 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082695 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082694 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082693 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082692 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082691 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082690 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082689 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082687 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082686 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082684 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
05/01/2003US20030082683 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
05/01/2003US20030082681 Nucleic acids, proteins, and antibodies
05/01/2003US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders
05/01/2003US20030082673 Homologous recombination expression vector for use as tool in the expression of recombinant genes in rodent cells
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082657 Oomycete FtsZ-mt as a target for oomycete-specific antimicrobials
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082641 A method of treating depression using a galr3 receptor antagonist
05/01/2003US20030082636 Antibody for use as tool in the treatment of blood disorders
05/01/2003US20030082634 Novel cell regulation factor TTO 20
05/01/2003US20030082628 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer and nervous system disorders
05/01/2003US20030082627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082619 Contiguous and partially overlapping cDNA sequences and polypeptides
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082603 Colon cancer marker
05/01/2003US20030082579 Generating library of preferential polypeptides; obtain nucleotide sequences, incubate with primers, amplify, recover amplification product, transform and express sequence incell, monitor and evaluate cell activity
05/01/2003US20030082575 Translation system for use in the generation of protein containing adjusted amino acid sequences
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082546 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders and cancer
05/01/2003US20030082542 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082541 Nucleotide sequences coding polypeptide for use in the treatment of skin disorders and cancer
05/01/2003US20030082540 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082534 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of brain and psychological disorders
05/01/2003US20030082199 Compositions and methods for the treatment of immune related diseases
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082188 Treatment of prostate cancer by inhibitors of NCAM2
05/01/2003US20030082179 Complexing antibody with poarathyroid hormone
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2793019A1 Humanized antibodies
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2464700A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464368A1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2460665A1 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
05/01/2003CA2454361A1 Humanized antibodies
04/2003
04/30/2003CN1415019A Method for making insulin precursors and insulin precursor analogus having improved fermentation yield in yeast
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1414976A Chimeric peptides used as immunogen and its antibody, and method for their use for immunization
04/30/2003CN1414974A Method for making insulin precursors and insulin precursor analogs
04/30/2003CN1414970A Transgenically produced fusion proteins
04/30/2003CN1414103A Human serine/threonine protein kitase, its coding sequence, preparation method and use
04/30/2003CN1414102A Binding region of erythrocyte binding protein of Plasmodium vivax and Plasmodium falciform
04/30/2003CN1414101A Desmocyte growth factor 11
04/30/2003CN1414100A Desmocyte growth factor 13
04/30/2003CN1414099A Linear expression carrier construction method need no clone
04/30/2003CN1414018A Binding region of erythrocyte binding protein of plasmodium vivax and plasmodium falciform
04/30/2003CN1414017A Preparation of anti cytoplasmic thymidine kinase-IgY and tumor diagnosis composition
04/30/2003CN1414016A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414015A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414014A Leptospira adventitial protein its code sequence and use
04/30/2003CN1107115C System for expression of heterologous antigens as fusion proteins
04/30/2003CN1107072C Programing cell death induced molecule II
04/30/2003CN1106858C Vaccine composition having antitumour activity and use there of in therapy of malignant diseases
04/30/2003CN1106846C Antitumor agent
04/29/2003US6555667 Hypoxia-regulated genes
1 ... 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 ... 1125